Your browser doesn't support javascript.
loading
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.
Pulliam, Nicholas; Fang, Fang; Ozes, Ali R; Tang, Jessica; Adewuyi, Adeoluwa; Keer, Harold; Lyons, John; Baylin, Stephen B; Matei, Daniela; Nakshatri, Harikrishna; Rassool, Feyruz V; Miller, Kathy D; Nephew, Kenneth P.
Afiliación
  • Pulliam N; Molecular and Cellular Biochemistry Department, Indiana University, Bloomington, Indiana.
  • Fang F; Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana.
  • Ozes AR; Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana.
  • Tang J; Molecular and Cellular Biochemistry Department, Indiana University, Bloomington, Indiana.
  • Adewuyi A; Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana.
  • Keer H; Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana.
  • Lyons J; Department of Radiation Oncology, School of Medicine, University of Maryland, Baltimore, Maryland.
  • Baylin SB; Astex Pharmaceuticals, Inc., Pleasanton, California.
  • Matei D; Astex Therapeutics Limited, Cambridge, United Kingdom.
  • Nakshatri H; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Rassool FV; Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Miller KD; Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Nephew KP; Department of Radiation Oncology, School of Medicine, University of Maryland, Baltimore, Maryland.
Clin Cancer Res ; 24(13): 3163-3175, 2018 07 01.
Article en En | MEDLINE | ID: mdl-29615458
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteína BRCA1 / Proteína BRCA2 / Epigénesis Genética / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Mutación Límite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteína BRCA1 / Proteína BRCA2 / Epigénesis Genética / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Mutación Límite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article